Susquehanna International Group
ONCT

Susquehanna International Group’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Susquehanna International Group’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-930
Closed -$26K – 14278
2022
Q1 		$26K Buy
930
+105
+13% +$3.82K ﹤0.01% 12553
2021
Q4 		$37K Sell
825
-3,310
-80% -$223K ﹤0.01% 12688
2021
Q3 		$345K Sell
4,135
-6,355
-61% -$526K ﹤0.01% 10278
2021
Q2 		$997K Buy
10,490
+1,335
+15% +$158K ﹤0.01% 7762
2021
Q1 		$1.52M Buy
9,155
+7,805
+578% +$1.03M ﹤0.01% 6602
2020
Q4 		$132K Buy
+1,350
New +$85.4K ﹤0.01% 10340
2019
Q2 		– Sell
-101
Closed -$17K – 10999
2019
Q1 		$17K Buy
101
+23
+29% +$3.43K ﹤0.01% 8612
2018
Q4 		$9K Sell
78
-281
-78% -$56.2K ﹤0.01% 8755
2018
Q3 		$79K Buy
+359
New +$862K ﹤0.01% 8687
2016
Q1 		– Sell
-15
Closed -$15K – 9838
2015
Q4 		$15K Hold
15
– – ﹤0.01% 9262
2015
Q3 		$16K Hold
15
– – ﹤0.01% 9519
2015
Q2 		$30K Buy
15
+3
+25% +$4.26K ﹤0.01% 9949
2015
Q1 		$11K Sell
12
-28
-70% -$27.8K ﹤0.01% 9306
2014
Q4 		$41K Hold
40
– – ﹤0.01% 9397
2014
Q3 		$41K Sell
40
-2
-5% -$2.95K ﹤0.01% 9254
2014
Q2 		$81K Sell
42
-37
-47% -$73.2K ﹤0.01% 9482
2014
Q1 		$169K Sell
79
-87
-52% -$217K ﹤0.01% 8349
2013
Q4 		$383K Sell
166
-9
-5% -$20.6K ﹤0.01% 7180
2013
Q3 		$493K Buy
175
+45
+35% +$224K ﹤0.01% 6449
2013
Q2 		$1.21M Buy
+130
New +$1M ﹤0.01% 4687

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PPW
Pasadena Private Wealth Pasadena, California $723M AUM 18.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Susquehanna International Group's ONCT Position: Q3 2024 in Review

Susquehanna International Group sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q3 2024, closing a stake of 15,206 shares — an estimated $116K sold.

Susquehanna International Group first reported a position in ONCT in Q2 2013 and held it in 27 quarters. The position peaked at $4.17M in Q1 2021. 23 funds tracked by Wall St. Rank hold ONCT as of Q3 2024.

  • Susquehanna International Group reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group sold 15,206 Oncternal Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $116K.
  • Susquehanna International Group first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q2 2013 and held it in 27 quarters.
  • Susquehanna International Group's Oncternal Therapeutics, Inc. Common Stock position peaked at $4.17M in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.